ER- Breast CA Risk Up for African-Americans With T2DM

This article originally appeared here.
Share this content:
ER- Breast CA Risk Up for African-Americans With T2DM
ER- Breast CA Risk Up for African-Americans With T2DM

WEDNESDAY, Nov. 15, 2017 (HealthDay News) -- African-American (AA) women with type 2 diabetes (T2D) appear to be at increased risk of developing estrogen receptor-negative (ER-) breast cancer, with the highest risk among nonobese individuals, according to a study published online Nov. 15 in Cancer Research.

Julie R. Palmer, Sc.D., from Slone Epidemiology Center at Boston University, and colleagues examined the correlation between T2D and incidence of ER- and ER+ breast cancer using data from the Black Women's Health Study, which enrolled AA women in 1995.

The researchers identified 1,851 incident invasive breast cancers during 847,934 person-years of follow-up, including 914 ER+ and 468 ER- cases. For overall breast cancer incidence, the hazard ratio was 1.18 (95 percent confidence interval, 1 to 1.4) for T2D versus no T2D; ER- cancer accounted for the increase, with hazard ratios of 1.02 (95 percent confidence interval, 0.8 to 1.31) and 1.43 (95 percent confidence interval, 1.03 to 2) for ER+ and ER- cancer, respectively. The highest hazard ratio for T2D and ER- breast cancer was seen for nonobese women (1.92; 95 percent confidence interval, 1.22 to 3.04).

"Given the high prevalence of T2D in AA women, the observed association could, in part, explain racial disparities in incidence of ER- breast cancer," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »